EMEA news
The National Institute for Health and Care Excellence (NICE) has recommended the Sleepio app as an effective alternative to sleeping pills.
In its guidance, NICE states the app, created by digital therapeutics (DTx) firm Big Health, is a safe and effective treatment for people suffering from insomnia.
It adds that the app could save the NHS money and reduce prescriptions of medicines such as...
Digital therapeutics firm, Sidekick Health has joined forces with pharma giant Pfizer to launch an integrated digital therapeutics solution for Atopic Dermatitis (AD).
The solution will be rolled-out in the UK first, followed by Belgium, Norway, the Netherlands, Sweden, France, Ireland, and Japan later this year.
This marks the next phase of a growing collaboration between Sidekick and Pfizer to...
Oxford Drug Design raises £2.2M to develop AI-based drug discovery programme
Biotechnology firm Oxford Drug Design Limited (ODD) has raised £2.2M in funding from existing investors ACF Investors, o2h Ventures, Meltwind Advisory, several returning angels and new investors and the US-based R42 Group.
The Oxford University spinout has created an artificial intelligence (AI) AI proprietary platform...
Demand for mental health services has soared since the COVID-19 pandemic. In the UK alone an estimated 1.6 million people are awaiting treatment, while a further eight million who do not qualify for NHS help are experiencing day-to-day challenges.
Increasingly digital therapeutics (DTx) are being considered as an option to fill the gaps in healthcare provision. They have the potential to be woven...
Free mental health app available to 1 million South Yorkshire NHS users
An emotional wellness app is being offered to over 16s in the UK's South Yorkshire for free, to help manage low moods, reduce stress and improve sleep.
The myStrength app has been commissioned by the South Yorkshire Integrated Care System (ICS) and is being delivered by Consultant Connect, part of the Teladoc Group.
Users are...
Digital therapeutics (DTx) firm Sidekick Health today announced a raise of $55 million (€52M) in Series B funding.
The round was led by London-based venture capital firm Novator Ventures, with additional participation from Wellington Partners, Asabys Partners, and Frumtak Ventures, and a US-based strategic investor that will be revealed at a later stage.
WHAT IT DOES
Sidekick develops and...
AI tool receives UK regulatory approval to support urgent skin cancer cases
Artificial intelligence (AI) dermatology firm Skin Analytics has received Class IIA status under the UK Medical Device Regulations 2002 for its device, DERM.
DERM uses machine learning to support clinicians in recognising the most common malignant, pre-malignant and benign skin lesions.
James Hamlyn, quality assurance...
Main Capital Partners acquires Finnish virtual healthcare specialist VideoVisit
Software investor Main Capital Partners has announced the acquisition of a majority stake in virtual healthcare provider VideoVisit.
VideoVisit has more than 200 municipalities in Finland as customers, including Helsinki, Espoo, Vantaa, Tampere and Turku. The firm provides a software platform designed to digitalise...
Mayden and SilverCloud Health partner to provide online mental health platform
People seeking support for their mental health can now receive instant digital therapy support, following a collaboration between digital care record supplier Mayden and online cognitive behavioural therapy solutions provider SilverCloud Health.
The ‘Direct to Digital’ approach is being rolled-out at mental health...
A Cairo-based healthtech startup focused on providing mental health services in the Middle East and North Africa (MENA) has just secured one of the largest investment rounds for its sector in the region.
O7 Therapy – a digital platform and smartphone app that specialises in online therapy, corporate wellness programmes, and psychoeducational resources for “Arabic-speaking users” – has raised a...
_7_0.jpg?itok=9zlzu-_8 "With the need for mental health support growing, could DTx be the key to making treatment more accessible?")
